BAX
Baxter International Inc
NYSE: BAX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$23.48
-0.04% today
Updated 2026-09-24
Market cap
$11.85B
P/E ratio
—
P/S ratio
1.03x
EPS (TTM)
$-1.88
Dividend yield
0.88%
52W range
$16 – $30
Volume
6.7M
Baxter International Inc (BAX) Insider transactions
Net insider activity
Net buying (2,788,353 shares)
Buy transactions
56
Sell transactions
44
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-02 | HIDER, ANDREW P. | Director, President and CEO | Sale | 54,276 | $25.70 | $1.39M |
| 2026-09-02 | FOSTER, JULIE | President, Front Line Care | Sale | 2,098 | $25.70 | $53918.60 |
| 2026-09-01 | TEAFF, JAMES | President, CCS | Sale | 750 | $25.48 | $19110.00 |
| 2026-06-02 | WALLACE, STEVEN P. | President, Adv. Surgery | Sale | 153 | $18.68 | $2858.04 |
| 2026-06-02 | TEAFF, JAMES | President, CCS | Sale | 321 | $18.68 | $5996.28 |
| 2026-06-01 | ZIELINSKI, ANITA A | SVP, Interim CFO, CAO & Cntrlr | Buy | 13,426 | — | — |
| 2026-05-05 | WILKES, DAVID S. | Director | Buy | 12,836 | — | — |
| 2026-05-05 | WENDELL, AMY MCBRIDE | Director | Buy | 12,836 | — | — |
| 2026-05-05 | SHAFER, DAVID BRENT | Director, Chair of the Board | Buy | 12,836 | — | — |
| 2026-05-05 | SCHLICHTING, NANCY M | Director | Buy | 12,836 | — | — |
| 2026-05-05 | MORRISON, PATRICIA | Director | Buy | 12,836 | — | — |
| 2026-05-05 | MCDONNELL, MICHAEL R. | Director | Buy | 12,836 | — | — |
| 2026-05-05 | CRAIG, JEFFREY A | Director | Buy | 12,836 | — | — |
| 2026-05-05 | AMPOFO, WILLIAM A. II | Director | Buy | 12,836 | — | — |
| 2026-03-06 | ZIELINSKI, ANITA A | SVP, CAO and Controller | Sale | 1,932 | $17.69 | $34177.08 |
| 2026-03-06 | SORIANO, MARIA CECILIA | Group Pres., ITT & Pharma. | Sale | 2,848 | $17.69 | $50381.12 |
| 2026-03-06 | ROSENBLOOM, DAVID S. | EVP and General Counsel | Sale | 6,620 | $17.69 | $117107.80 |
| 2026-03-06 | RASUL, REAZUR | EVP,Group Pres,Healthcare | Sale | 12,674 | $17.69 | $224203.06 |
| 2026-03-06 | GRADE, JOEL T. | EVP and CFO | Sale | 8,153 | $17.69 | $144226.57 |
| 2026-03-02 | SORIANO, MARIA CECILIA | Group Pres., ITT & Pharma. | Sale | 1,852 | $19.69 | $36465.88 |
| 2026-03-02 | ROSENBLOOM, DAVID S. | EVP and General Counsel | Sale | 1,336 | $19.69 | $26305.84 |
| 2026-03-02 | RASUL, REAZUR | EVP,Group Pres,Healthcare | Sale | 1,614 | $19.69 | $31779.66 |
| 2026-02-27 | ZIELINSKI, ANITA A | SVP, CAO and Controller | Buy | 30,864 | — | — |
| 2026-02-27 | SORIANO, MARIA CECILIA | Group Pres., ITT & Pharma. | Buy | 57,471 | — | — |
| 2026-02-27 | SORIANO, MARIA CECILIA | Group Pres., ITT & Pharma. | Buy | 23,742 | — | — |
| 2026-02-27 | ROSENBLOOM, DAVID S. | EVP and General Counsel | Buy | 64,655 | — | — |
| 2026-02-27 | ROSENBLOOM, DAVID S. | EVP and General Counsel | Buy | 26,709 | — | — |
| 2026-02-27 | HIDER, ANDREW P. | Director, President and CEO | Buy | 488,506 | — | — |
| 2026-02-27 | HIDER, ANDREW P. | Director, President and CEO | Buy | 201,804 | — | — |
| 2026-02-27 | GRADE, JOEL T. | EVP and CFO | Buy | 103,448 | — | — |
| 2026-02-27 | GRADE, JOEL T. | EVP and CFO | Buy | 42,735 | — | — |
| 2026-02-27 | CARLISLE, CYNTHIA | Executive Vice President, CHRO | Buy | 43,103 | — | — |
| 2026-02-27 | CARLISLE, CYNTHIA | Executive Vice President, CHRO | Buy | 17,806 | — | — |
| 2026-02-27 | CARLISLE, CYNTHIA | Executive Vice President, CHRO | Buy | 11,871 | — | — |
| 2026-02-13 | MCDONNELL, MICHAEL R. | Director | Buy | 1,811 | — | — |
| 2026-02-09 | SORIANO, MARIA CECILIA | Group Pres., ITT & Pharma. | Buy | 2,273 | — | — |
| 2026-02-09 | SORIANO, MARIA CECILIA | Group Pres., ITT & Pharma. | Sale | 918 | $21.73 | $19948.14 |
| 2026-02-09 | ROSENBLOOM, DAVID S. | EVP and General Counsel | Buy | 17,055 | — | — |
| 2026-02-09 | ROSENBLOOM, DAVID S. | EVP and General Counsel | Sale | 5,225 | $21.73 | $113539.25 |
| 2026-02-09 | RASUL, REAZUR | EVP,Group Pres,Healthcare | Buy | 18,951 | — | — |
| 2026-02-09 | RASUL, REAZUR | EVP,Group Pres,Healthcare | Sale | 5,770 | $21.73 | $125382.10 |
| 2026-02-09 | GRADE, JOEL T. | EVP and CFO | Buy | 30,504 | — | — |
| 2026-02-09 | GRADE, JOEL T. | EVP and CFO | Sale | 9,144 | $21.73 | $198699.12 |
| 2025-12-12 | MASON, JEANNE K | EVP, Chief HR Officer | Sale | 650 | $19.15 | $12447.50 |
| 2025-12-01 | GRADE, JOEL T. | EVP and CFO | Sale | 8,288 | $19.08 | $158135.04 |
| 2025-09-02 | SONIG, ALOK | EVP,Group President,Pharma | Sale | 3,191 | $24.17 | $77126.47 |
| 2025-09-02 | HIDER, ANDREW P. | Director, President and CEO | Buy | 465,651 | — | — |
| 2025-09-02 | HIDER, ANDREW P. | Director, President and CEO | Buy | 236,237 | — | — |
| 2025-09-02 | HIDER, ANDREW P. | Director, President and CEO | Buy | 131,813 | — | — |
| 2025-09-02 | GRADE, JOEL T. | EVP and CFO | Buy | 102,712 | — | — |
| 2025-09-02 | BORZI, JAMES W | EVP,Chief Supply Chain Officer | Sale | 1,848 | $24.17 | $44666.16 |
| 2025-08-19 | SHAFER, DAVID BRENT | Director, Chair of the Board | Sale | 31,337 | $24.33 | $762429.21 |
| 2025-06-02 | ROSENBLOOM, DAVID S. | EVP and General Counsel | Sale | 16,548 | $29.55 | $488993.40 |
| 2025-05-06 | WILKES, DAVID S. | Director | Buy | 7,183 | — | — |
| 2025-05-06 | WENDELL, AMY MCBRIDE | Director | Buy | 7,183 | — | — |
| 2025-05-06 | SMITH, CATHY R | Director | Buy | 7,183 | — | — |
| 2025-05-06 | SCHLICHTING, NANCY M | Director | Buy | 7,183 | — | — |
| 2025-05-06 | RUSCKOWSKI, STEPHEN H | Director | Buy | 7,183 | — | — |
| 2025-05-06 | OESTERLE, STEPHEN N. | Director | Buy | 7,183 | — | — |
| 2025-05-06 | MORRISON, PATRICIA | Director | Buy | 7,183 | — | — |
| 2025-05-06 | CRAIG, JEFFREY A | Director | Buy | 7,183 | — | — |
| 2025-05-06 | AMPOFO, WILLIAM A. II | Director | Buy | 7,183 | — | — |
| 2025-03-06 | ZIELINSKI, ANITA A | SVP, CAO and Controller | Buy | 17,123 | — | — |
| 2025-03-06 | SONIG, ALOK | EVP,Group President,Pharma | Buy | 99,905 | — | — |
| 2025-03-06 | SONIG, ALOK | EVP,Group President,Pharma | Buy | 29,966 | — | — |
| 2025-03-06 | SONIG, ALOK | EVP,Group President,Pharma | Sale | 10,839 | $35.44 | $384134.16 |
| 2025-03-06 | ROSENBLOOM, DAVID S. | EVP and General Counsel | Buy | 58,873 | — | — |
| 2025-03-06 | ROSENBLOOM, DAVID S. | EVP and General Counsel | Buy | 17,658 | — | — |
| 2025-03-06 | ROSENBLOOM, DAVID S. | EVP and General Counsel | Sale | 4,922 | $35.44 | $174435.68 |
| 2025-03-06 | RASUL, REAZUR | EVP,Group Pres,Healthcare | Buy | 87,417 | — | — |
| 2025-03-06 | RASUL, REAZUR | EVP,Group Pres,Healthcare | Buy | 26,220 | — | — |
| 2025-03-06 | RASUL, REAZUR | EVP,Group Pres,Healthcare | Sale | 9,341 | $35.44 | $331045.04 |
| 2025-03-06 | MASON, JEANNE K | EVP, Chief HR Officer | Buy | 52,331 | — | — |
| 2025-03-06 | MASON, JEANNE K | EVP, Chief HR Officer | Buy | 15,696 | — | — |
| 2025-03-06 | MASON, JEANNE K | EVP, Chief HR Officer | Sale | 4,375 | $35.44 | $155050.00 |
| 2025-03-06 | KNIGHT, HEATHER | EVP, Chief Operating Officer | Buy | 118,934 | — | — |
| 2025-03-06 | KNIGHT, HEATHER | EVP, Chief Operating Officer | Buy | 35,674 | — | — |
| 2025-03-06 | KNIGHT, HEATHER | EVP, Chief Operating Officer | Sale | 13,634 | $35.44 | $483188.96 |
| 2025-03-06 | GRADE, JOEL T. | EVP and CFO | Buy | 98,478 | — | — |
| 2025-03-06 | GRADE, JOEL T. | EVP and CFO | Buy | 29,538 | — | — |
| 2025-03-06 | GRADE, JOEL T. | EVP and CFO | Sale | 4,306 | $35.44 | $152604.64 |
| 2025-03-06 | BORZI, JAMES W | EVP,Chief Supply Chain Officer | Buy | 33,302 | — | — |
| 2025-03-06 | BORZI, JAMES W | EVP,Chief Supply Chain Officer | Buy | 9,989 | — | — |
| 2025-03-06 | BORZI, JAMES W | EVP,Chief Supply Chain Officer | Sale | 3,262 | $35.44 | $115605.28 |
| 2025-03-03 | SONIG, ALOK | EVP,Group President,Pharma | Sale | 1,936 | $34.86 | $67488.96 |
| 2025-03-03 | ROSENBLOOM, DAVID S. | EVP and General Counsel | Sale | 1,312 | $34.86 | $45736.32 |
| 2025-03-03 | RASUL, REAZUR | EVP,Group Pres,Healthcare | Sale | 1,987 | $34.86 | $69266.82 |
| 2025-03-03 | MASON, JEANNE K | EVP, Chief HR Officer | Sale | 1,479 | $34.86 | $51557.94 |
| 2025-03-03 | KNIGHT, HEATHER | EVP, Chief Operating Officer | Sale | 3,344 | $34.86 | $116571.84 |
| 2025-03-03 | BORZI, JAMES W | EVP,Chief Suppy Chain Officer | Sale | 1,339 | $34.86 | $46677.54 |
| 2025-02-05 | SHAFER, DAVID BRENT | Director, Interim CEO and Chair | Buy | 76,289 | — | — |
| 2025-01-31 | TOTH, CHRISTOPHER A. | EVP, Group Pres, Kidney Care | Sale | 25,372 | $32.56 | $826112.32 |
| 2024-12-31 | TOTH, CHRISTOPHER A. | EVP,Group Pres, Kidney Care | Sale | 32,610 | $29.16 | $950907.60 |
| 2024-12-13 | ALMEIDA, JOSE E | Chairman, CEO, President | Sale | 5,966 | $30.32 | $180889.12 |
| 2024-12-02 | RASUL, REAZUR | EVP,Group Pres,Healthcare | Sale | 2,032 | $33.55 | $68173.60 |
| 2024-12-02 | KNIGHT, HEATHER | EVP, Group Pres, Med Products | Sale | 6,041 | $33.55 | $202675.55 |
| 2024-12-02 | GRADE, JOEL T. | EVP and CFO | Sale | 6,612 | $33.55 | $221832.60 |
| 2024-09-09 | CRAIG, JEFFREY A | Director | Buy | 3,472 | — | — |
| 2024-09-03 | SONIG, ALOK | EVP,Group President, Pharma | Sale | 3,054 | $37.85 | $115593.90 |
| 2024-09-03 | BORZI, JAMES W | EVP,Chief Supply Chain Officer | Sale | 1,685 | $37.85 | $63777.25 |
Frequently asked questions
Are BAX insiders buying or selling?
Over the transactions on record, BAX insiders have been net buyers, with about $8.97M in stock sold across 44 sales. The entries tagged as buys are stock grants and option exercises recorded at $0, not open-market purchases.
Does insider selling at BAX mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which BAX insiders are selling the most?
Recent selling is concentrated in a few names. TOTH, CHRISTOPHER A. accounts for the largest share on record, with about $1.78M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.